Anti-DOK7抗体(ab75049)
Key features and details
- Rabbit polyclonal to DOK7
- Suitable for: WB, IHC-P, ICC/IF
- Reacts with: Mouse, Human
- Isotype: IgG
概述
-
产品名称
Anti-DOK7抗体 -
描述
兔多克隆抗体to DOK7 -
宿主
Rabbit -
经测试应用
适用于: WB, IHC-P, ICC/IFmore details -
种属反应性
与反应: Mouse, Human -
免疫原
Synthetic peptide derived from N-terminus of human DOK7.
-
常规说明
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
性能
-
形式
Liquid -
存放说明
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles. -
存储溶液
pH: 7.40
Preservative: 0.02% Sodium azide
Constituents: 50% Glycerol (glycerin, glycerine), 0.87% Sodium chloride, PBS -
Concentration information loading...
-
纯度
Immunogen affinity purified -
克隆
多克隆 -
同种型
IgG -
研究领域
相关产品
-
Compatible Secondaries
-
Isotype control
应用
The Abpromise guarantee
Abpromise™承诺保证使用ab75049于以下的经测试应用
“应用说明”部分 下显示的仅为推荐的起始稀释度;实际最佳的稀释度/浓度应由使用者检定。
应用 | Ab评论 | 说明 |
---|---|---|
WB |
1/500 - 1/1000. Detects a band of approximately 53 kDa (predicted molecular weight: 53 kDa).
|
|
IHC-P |
1/50 - 1/100.
|
|
ICC/IF |
1/500 - 1/1000.
|
说明 |
---|
WB
1/500 - 1/1000. Detects a band of approximately 53 kDa (predicted molecular weight: 53 kDa). |
IHC-P
1/50 - 1/100. |
ICC/IF
1/500 - 1/1000. |
靶标
-
功能
Probable muscle-intrinsic activator of MUSK that plays an essential role in neuromuscular synaptogenesis. Acts in aneural activation of MUSK and subsequent acetylcholine receptor (AchR) clustering in myotubes. Induces autophosphorylation of MUSK. -
组织特异性
Preferentially expressed in skeletal muscle and heart Present in thigh muscle, diaphragm and heart but not in the liver or spleen (at protein level). -
疾病相关
Defects in DOK7 are the cause of familial limb-girdle myasthenia autosomal recessive (LGM) [MIM:254300]; also called congenital myasthenic syndrome type 1B or CMS1B. LGM is a congenital myasthenic syndrome characterized by a typical 'limb girdle' pattern of muscle weakness with small, simplified neuromuscular junctions but normal acetylcholine receptor and acetylcholinesterase function. -
序列相似性
Contains 1 IRS-type PTB domain.
Contains 1 PH domain. -
细胞定位
Cell membrane. Cell junction > synapse. Accumulates at neuromuscular junctions. - Information by UniProt
-
数据库链接
- Entrez Gene: 285489 Human
- Entrez Gene: 231134 Mouse
- SwissProt: Q18PE1 Human
- SwissProt: Q18PE0 Mouse
- Unigene: 122110 Human
- Unigene: 701584 Human
- Unigene: 205483 Mouse
-
别名
- Docking protein 7 antibody
- DOK 7 antibody
- DOK7 antibody
see all
图片
-
All lanes : Anti-DOK7 antibody (ab75049) at 1/500 dilution
Lane 1 : extracts from mouse brain cells
Lane 2 : extracts from mouse brain cells with immunising peptide at 5 µg
Lysates/proteins at 5 µg per lane.
Predicted band size: 53 kDa
Observed band size: 53 kDa
Additional bands at: 46 kDa, 80 kDa. We are unsure as to the identity of these extra bands. -
Human brain tissue with ab75049 at 1/50 dilution, in the absence and presence of the immunising peptide.
-
HepG2 cells with ab75049 at 1/500 dilution, in the absence and presence of the immunising peptide.
实验方案
数据表及文件
-
SDS download
-
Datasheet download
文献 (3)
ab75049 被引用在 3 文献中.
- Yue C et al. DOK7 Inhibits Cell Proliferation, Migration, and Invasion of Breast Cancer via the PI3K/PTEN/AKT Pathway. J Oncol 2021:4035257 (2021). PubMed: 33552156
- Huot JR et al. Muscle weakness caused by cancer and chemotherapy is associated with loss of motor unit connectivity. Am J Cancer Res 11:2990-3001 (2021). PubMed: 34249440
- Zhao H et al. DOK7V1 influences the malignant phenotype of lung cancer cells through PI3K/AKT/mTOR and FAK/paxillin signaling pathways. Int J Oncol 54:381-389 (2019). PubMed: 30431081